Lower CRC risk with ACEis, ARBs?
01 Sep 2020
byRoshini Claire Anthony
The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) may be associated with a reduced risk of colorectal cancer (CRC), according to a retrospective cohort study from Hong Kong.
Lower CRC risk with ACEis, ARBs?
01 Sep 2020
